Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alcoholism

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 179 articles:
HTML format



Single Articles


    January 2022
  1. RADFORD-SMITH DE, Patel PJ, Irvine KM, Russell A, et al
    Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism.
    PLoS One. 2022;17:e0261555.
    PubMed     Abstract available


  2. S HASHEMI N, Skogen JC, Sevic A, Thorrisen MM, et al
    A systematic review and meta-analysis uncovering the relationship between alcohol consumption and sickness absence. When type of design, data, and sickness absence make a difference.
    PLoS One. 2022;17:e0262458.
    PubMed     Abstract available


  3. POWELL LM, Leider J
    Impact of the Seattle Sweetened Beverage Tax on substitution to alcoholic beverages.
    PLoS One. 2022;17:e0262578.
    PubMed     Abstract available


  4. JOLEX A, Kaluwa B
    Crowding Out Effects of Alcohol Consumption Expenditure on Household Resource Allocation in Malawi.
    PLoS One. 2022;17:e0263330.
    PubMed     Abstract available


  5. TOVMASYAN A, Monk RL, Heim D
    Towards an affect intensity regulation hypothesis: Systematic review and meta-analyses of the relationship between affective states and alcohol consumption.
    PLoS One. 2022;17:e0262670.
    PubMed     Abstract available


  6. ASADULLAH M, Shivashankar R, Shalimar, Kandasamy D, et al
    Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population.
    PLoS One. 2022;17:e0263768.
    PubMed     Abstract available


  7. THOMAS KL, Root CL, Peterson JM
    Transgenic overexpression of CTRP3 does not prevent alcohol induced hepatic steatosis in female mice.
    PLoS One. 2022;17:e0258557.
    PubMed     Abstract available


  8. FERNANDEZ T, Vinuela M, Vidal C, Barrera F, et al
    Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263931.
    PubMed     Abstract available


  9. MORISHITA A, Tadokoro T, Fujihara S, Iwama H, et al
    Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model.
    PLoS One. 2022;17:e0261310.
    PubMed     Abstract available


  10. CHOSY EJ, Edland S, Launer L, White LR, et al
    Midlife alcohol consumption and later life cognitive impairment: Light drinking is not protective and APOE genotype does not change this relationship.
    PLoS One. 2022;17:e0264575.
    PubMed     Abstract available


  11. SANTOS MGR, Sanchez ZM, Hughes K, Gee I, et al
    Pre-drinking, alcohol consumption and related harms amongst Brazilian and British university students.
    PLoS One. 2022;17:e0264842.
    PubMed     Abstract available


  12. HAMADA S, Takata T, Yamada K, Yamamoto M, et al
    Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model.
    PLoS One. 2022;17:e0265461.
    PubMed     Abstract available


  13. KIMER N, Meldgaard M, Hamberg O, Kronborg TM, et al
    The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial.
    PLoS One. 2022;17:e0264278.
    PubMed     Abstract available


  14. DONOGHUE K, Hermann L, Brobbin E, Drummond C, et al
    The rates and measurement of adherence to acamprosate in randomised controlled clinical trials: A systematic review.
    PLoS One. 2022;17:e0263350.
    PubMed     Abstract available


  15. ANENI EC, Saeed GJ, Bittencourt MS, Cainzos-Achirica M, et al
    Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals.
    PLoS One. 2022;17:e0266505.
    PubMed     Abstract available


  16. CAROL M, Perez-Guasch M, Sola E, Cervera M, et al
    Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.
    PLoS One. 2022;17:e0265153.
    PubMed     Abstract available


  17. SALMAN M, Kamel MA, El-Nabi SEH, Ismail AHA, et al
    The regulation of HBP1, SIRT1, and SREBP-1c genes and the related microRNAs in non-alcoholic fatty liver rats: The association with the folic acid anti-steatosis.
    PLoS One. 2022;17:e0265455.
    PubMed     Abstract available


  18. SARMADI N, Poustchi H, Ali Yari F, Radmard AR, et al
    Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease.
    PLoS One. 2022;17:e0266227.
    PubMed     Abstract available


  19. KUMAR RG, Esterov D, Adams RS, Corrigan JD, et al
    Changes in alcohol use and mood during the COVID-19 pandemic among individuals with traumatic brain injury: A difference-in-difference study.
    PLoS One. 2022;17:e0266422.
    PubMed     Abstract available


  20. KOVACS I, Gal BI, Horvath Z, Demeter I, et al
    Externalizing personality characteristics define clinically relevant subgroups of alcohol use disorder.
    PLoS One. 2022;17:e0265577.
    PubMed     Abstract available


  21. SUBHANI M, Talat U, Knight H, Morling JR, et al
    Characteristics of alcohol recovery narratives: Systematic review and narrative synthesis.
    PLoS One. 2022;17:e0268034.
    PubMed     Abstract available


  22. ACHARYA B, Dhakal C
    Risky health behaviors during the COVID-19 pandemic: Evidence from the expenditures on alcohol, non-alcoholic beverages, and tobacco products.
    PLoS One. 2022;17:e0268068.
    PubMed     Abstract available


    January 2021
  23. PEDRONI C, Dujeu M, Lebacq T, Desnouck V, et al
    Alcohol consumption in early adolescence: Associations with sociodemographic and psychosocial factors according to gender.
    PLoS One. 2021;16:e0245597.
    PubMed     Abstract available


  24. ESTRADA-MARTINEZ S, Perez-Alamos AR, Ibarra-Segovia M, Beristain-Garcia I, et al
    Seroepidemiology of Toxoplasma gondii infection in people with alcohol consumption in Durango, Mexico.
    PLoS One. 2021;16:e0245701.
    PubMed     Abstract available


  25. LIN X, You F, Liu H, Fang Y, et al
    Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245921.
    PubMed     Abstract available



  26. Correction: Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    PLoS One. 2021;16:e0247690.
    PubMed     Abstract available


  27. HENNEIN R, Mew EJ, Lowe SR
    Socio-ecological predictors of mental health outcomes among healthcare workers during the COVID-19 pandemic in the United States.
    PLoS One. 2021;16:e0246602.
    PubMed     Abstract available


  28. DARLING KEA, Locatelli I, Benghalem N, Nadin I, et al
    Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland.
    PLoS One. 2021;16:e0246579.
    PubMed     Abstract available


  29. SENGUPTA M, Abuirqeba S, Kameric A, Cecile-Valfort A, et al
    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.
    PLoS One. 2021;16:e0249316.
    PubMed     Abstract available


  30. ARIYA M, Koohpayeh F, Ghaemi A, Osati S, et al
    Assessment of the association between body composition and risk of non-alcoholic fatty liver.
    PLoS One. 2021;16:e0249223.
    PubMed     Abstract available


  31. KURODA H, Fujiwara Y, Abe T, Nagasawa T, et al
    Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis.
    PLoS One. 2021;16:e0249493.
    PubMed     Abstract available


  32. D'AMBROSIO R, Campi I, Maggioni M, Perbellini R, et al
    The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2021;16:e0249614.
    PubMed     Abstract available


  33. BAE CR, Zhang H, Kwon YG
    Correction: The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2021;16:e0249747.
    PubMed     Abstract available


  34. KOUTOUKIDIS DA, Morris E, Henry JA, Shammoon Y, et al
    What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250385.
    PubMed     Abstract available


  35. TAHA MM, Aneis YM, Mohamady HM, S A A, et al
    Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
    PLoS One. 2021;16:e0250337.
    PubMed     Abstract available


  36. CONGLY SE, Shaheen AA, Swain MG
    Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting.
    PLoS One. 2021;16:e0251741.
    PubMed     Abstract available


  37. YEN HH, Su PY, Huang SP, Wu L, et al
    Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
    PLoS One. 2021;16:e0252286.
    PubMed     Abstract available


  38. KIM JY, Park YM, Lee GN, Song HC, et al
    Association between toothbrushing and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0243686.
    PubMed     Abstract available


  39. DAYTON KA, Bril F, Barb D, Lai J, et al
    Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
    PLoS One. 2021;16:e0251449.
    PubMed     Abstract available


  40. RENNERT-MAY E, Leal J, Thanh NX, Lang E, et al
    The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study.
    PLoS One. 2021;16:e0252441.
    PubMed     Abstract available


  41. SUKAHRI S, Mohamed Shah FZ, Ismail AI, Koshy M, et al
    Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0253298.
    PubMed     Abstract available


  42. MORAN MW, Ramirez EP, Zook JD, Saarinen AM, et al
    Biophysical characterization and a roadmap towards the NMR solution structure of G0S2, a key enzyme in non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0249164.
    PubMed     Abstract available


  43. PRO G, Gilbert PA, Baldwin JA, Brown CC, et al
    Multilevel modeling of county-level excessive alcohol use, rurality, and COVID-19 case fatality rates in the US.
    PLoS One. 2021;16:e0253466.
    PubMed     Abstract available


  44. YOKOYAMA A, Yokoyama T, Kimura M, Matsushita S, et al
    Combinations of alcohol-induced flushing with genetic polymorphisms of alcohol and aldehyde dehydrogenases and the risk of alcohol dependence in Japanese men and women.
    PLoS One. 2021;16:e0255276.
    PubMed     Abstract available


  45. LEE Y, Mun E, Park S, Lee W, et al
    Long working hours are associated with a higher risk of non-alcoholic fatty liver disease: A large population-based Korean cohort study.
    PLoS One. 2021;16:e0255118.
    PubMed     Abstract available


  46. ERIKSEN LL, Nielsen MA, Laursen TL, Deleuran B, et al
    Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis.
    PLoS One. 2021;16:e0255574.
    PubMed     Abstract available


  47. MANTHEY J, Solovei A, Anderson P, Carr S, et al
    Can alcohol consumption in Germany be reduced by alcohol screening, brief intervention and referral to treatment in primary health care? Results of a simulation study.
    PLoS One. 2021;16:e0255843.
    PubMed     Abstract available


  48. MINICOZZI MR, Axlid EG, von Hippel FA, Espinoza J, et al
    Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish.
    PLoS One. 2021;16:e0254500.
    PubMed     Abstract available


  49. DANTAS DMM, Cahu TB, Oliveira CYB, Abadie-Guedes R, et al
    Chlorella vulgaris functional alcoholic beverage: Effect on propagation of cortical spreading depression and functional properties.
    PLoS One. 2021;16:e0255996.
    PubMed     Abstract available


  50. GAUME J, Grazioli VS, Paroz S, Fortini C, et al
    Developing a brief motivational intervention for young adults admitted with alcohol intoxication in the emergency department - Results from an iterative qualitative design.
    PLoS One. 2021;16:e0246652.
    PubMed     Abstract available


  51. O'DONNELL A, Schulte B, Manthey J, Schmidt CS, et al
    Primary care-based screening and management of depression amongst heavy drinking patients: Interim secondary outcomes of a three-country quasi-experimental study in Latin America.
    PLoS One. 2021;16:e0255594.
    PubMed     Abstract available


  52. VAN DEN TOREN SJ, van Grieken A, Raat H
    Associations of socio-demographic characteristics, well-being, school absenteeism, and substance use with recreational nitrous oxide use among adolescents: A cross-sectional study.
    PLoS One. 2021;16:e0247230.
    PubMed     Abstract available


  53. LI M, Hu M, Yue Z, Zhang Y, et al
    The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus.
    PLoS One. 2021;16:e0257391.
    PubMed     Abstract available


  54. KAPS L, Ahlbrand CJ, Gadban R, Nagel M, et al
    Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
    PLoS One. 2021;16:e0249342.
    PubMed     Abstract available


  55. WANG IJ, Bae BK, Cho YM, Cho SJ, et al
    Effect of acute alcohol intoxication on mortality, coagulation, and fibrinolysis in trauma patients.
    PLoS One. 2021;16:e0248810.
    PubMed     Abstract available


  56. HANNA CHAIM C, Santana GL, de Vries Albertin P, Silveira CM, et al
    Alcohol use patterns and disorders among individuals with personality disorders in the Sao Paulo Metropolitan Area.
    PLoS One. 2021;16:e0248403.
    PubMed     Abstract available


  57. JACKSON J, Donaldson DI, Dering B
    The morning after the night before: Alcohol-induced blackouts impair next day recall in sober young adults.
    PLoS One. 2021;16:e0250827.
    PubMed     Abstract available


  58. KNIGHT JK, Salali GD, Sikka G, Derkx I, et al
    Quantifying patterns of alcohol consumption and its effects on health and wellbeing among BaYaka hunter-gatherers: A mixed-methods cross-sectional study.
    PLoS One. 2021;16:e0258384.
    PubMed     Abstract available


  59. OSCAR-BERMAN M, Ruiz SM, Marinkovic K, Valmas MM, et al
    Brain responsivity to emotional faces differs in men and women with and without a history of alcohol use disorder.
    PLoS One. 2021;16:e0248831.
    PubMed     Abstract available



  60. Retraction: Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.
    PLoS One. 2021;16:e0259219.
    PubMed    


  61. KASHYAP GC, Govind B, Srivastava S, R V, et al
    A true face of Indian married couples: Effect of age and education on control over own sexuality and sexual violence.
    PLoS One. 2021;16:e0254005.
    PubMed     Abstract available


  62. HEITMANN J, van Hemel-Ruiter ME, Huisman M, Ostafin BD, et al
    Effectiveness of attentional bias modification training as add-on to regular treatment in alcohol and cannabis use disorder: A multicenter randomized control trial.
    PLoS One. 2021;16:e0252494.
    PubMed     Abstract available


  63. CHARTIER KG, Guidry JPD, Lee CA, Buckley TD, et al
    At home and online during the early months of the COVID-19 pandemic and the relationship to alcohol consumption in a national sample of U.S. adults.
    PLoS One. 2021;16:e0259947.
    PubMed     Abstract available


  64. HOLMES HM, Jove AG, Tan MC, El-Serag HB, et al
    Alcohol consumption and the risk of gastric intestinal metaplasia in a U.S. Veterans population.
    PLoS One. 2021;16:e0260019.
    PubMed     Abstract available


  65. HOWLETT N, Garcia-Iglesias J, Breslin G, Bartington S, et al
    Remote delivery of alcohol and/or substance misuse interventions for adults: A systematic review protocol.
    PLoS One. 2021;16:e0259525.
    PubMed     Abstract available


  66. FILLMORE N, Bell S, Shen C, Nguyen V, et al
    Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study.
    PLoS One. 2021;16:e0259061.
    PubMed     Abstract available


  67. LEGAS G, Asnakew S, Belete A, Beyene GM, et al
    Magnitude and correlates of alcohol use disorder in south Gondar zone, northwest Ethiopia: A community based cross-sectional study.
    PLoS One. 2021;16:e0257804.
    PubMed     Abstract available


  68. MINNERLY C, Shokry IM, To W, Callanan JJ, et al
    Characteristic changes in EEG spectral powers of patients with opioid-use disorder as compared with those with methamphetamine- and alcohol-use disorders.
    PLoS One. 2021;16:e0248794.
    PubMed     Abstract available


  69. AGUERREBERE M, Frias SM, Smith Fawzi MC, Lopez R, et al
    Intimate partner violence types and symptoms of common mental disorders in a rural community of Chiapas, Mexico: Implications for global mental-health practice.
    PLoS One. 2021;16:e0256850.
    PubMed     Abstract available


  70. GUTEMA H, Debela Y, Walle B, Reba K, et al
    Predicting binge drinking among university students: Application of integrated behavioral model.
    PLoS One. 2021;16:e0254185.
    PubMed     Abstract available


  71. GOYALE A, Jain A, Smith C, Papatheodoridi M, et al
    Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
    PLoS One. 2021;16:e0260313.
    PubMed     Abstract available


  72. JANG DK, Ahn DW, Lee KL, Kim BG, et al
    Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis.
    PLoS One. 2021;16:e0260309.
    PubMed     Abstract available


  73. KONRAD G, Leong C, Bolton JM, Prior HJ, et al
    Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada: A whole-population cohort study.
    PLoS One. 2021;16:e0257025.
    PubMed     Abstract available


  74. ALVES RM, Santos EGO, Barbosa IR
    Abuse of alcohol among farmers: Prevalence and associated factors.
    PLoS One. 2021;16:e0254904.
    PubMed     Abstract available


  75. CORDOBA E, Garofalo R, Kuhns LM, Pearson C, et al
    Risk-taking behaviors in adolescent men who have sex with men (MSM): An association between homophobic victimization and alcohol consumption.
    PLoS One. 2021;16:e0260083.
    PubMed     Abstract available


  76. ESKRIDGE W, Vierling JM, Gosbee W, Wan GA, et al
    Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE).
    PLoS One. 2021;16:e0260320.
    PubMed     Abstract available


  77. PARK SJ, Lee SJ, Kim H, Kim JK, et al
    Machine learning prediction of dropping out of outpatients with alcohol use disorders.
    PLoS One. 2021;16:e0255626.
    PubMed     Abstract available


  78. VIGOUROUX A, Garret C, Lascarrou JB, Martin M, et al
    Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors.
    PLoS One. 2021;16:e0261443.
    PubMed     Abstract available


  79. TEVIK K, Bergh S, Selbaek G, Johannessen A, et al
    A systematic review of self-report measures used in epidemiological studies to assess alcohol consumption among older adults.
    PLoS One. 2021;16:e0261292.
    PubMed     Abstract available


  80. MCCRABB S, Mooney K, Wolfenden L, Gonzalez S, et al
    "He who pays the piper calls the tune": Researcher experiences of funder suppression of health behaviour intervention trial findings.
    PLoS One. 2021;16:e0255704.
    PubMed     Abstract available


  81. PERALES JC, Maldonado A, Lopez-Quirantes EM, Lopez-Torrecillas F, et al
    Association patterns of cannabis abuse and dependence with risk of problematic non-substance-related dysregulated and addictive behaviors.
    PLoS One. 2021;16:e0255872.
    PubMed     Abstract available


  82. CHEN Y, Hinton C, VanderWeele TJ
    School types in adolescence and subsequent health and well-being in young adulthood: An outcome-wide analysis.
    PLoS One. 2021;16:e0258723.
    PubMed     Abstract available


  83. SINGINI MG, Sitas F, Bradshaw D, Chen WC, et al
    Ranking lifestyle risk factors for cervical cancer among Black women: A case-control study from Johannesburg, South Africa.
    PLoS One. 2021;16:e0260319.
    PubMed     Abstract available


  84. AKOMBI-INYANG B, Ghimire PR, Archibong E, Woolley E, et al
    Association between intimate partner violence and male alcohol use and the receipt of perinatal care: Evidence from Nepal demographic and health survey 2011-2016.
    PLoS One. 2021;16:e0259980.
    PubMed     Abstract available


  85. RIBEIRO RM, Havik PJ, Craveiro I
    The circuits of healthcare: Understanding healthcare seeking behaviour-A qualitative study with tuberculosis patients in Lisbon, Portugal.
    PLoS One. 2021;16:e0261688.
    PubMed     Abstract available


    January 2020
  86. MELBY K, Fasmer OB, Henriksen TE, Grawe RW, et al
    Actigraphy assessment of motor activity and sleep in patients with alcohol withdrawal syndrome and the effects of intranasal oxytocin.
    PLoS One. 2020;15:e0228700.
    PubMed     Abstract available


  87. WAN YM, Li ZQ, Liu C, He YF, et al
    Mesenchymal stem cells reduce alcoholic hepatitis in mice via suppression of hepatic neutrophil and macrophage infiltration, and of oxidative stress.
    PLoS One. 2020;15:e0228889.
    PubMed     Abstract available


  88. OKAMOTO K, Koda M, Okamoto T, Onoyama T, et al
    Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0219412.
    PubMed     Abstract available


  89. HTET H, Saw YM, Saw TN, Htun NMM, et al
    Prevalence of alcohol consumption and its risk factors among university students: A cross-sectional study across six universities in Myanmar.
    PLoS One. 2020;15:e0229329.
    PubMed     Abstract available


  90. LEMOINE M, Gmel G, Foster S, Marmet S, et al
    Multiple trajectories of alcohol use and the development of alcohol use disorder: Do Swiss men mature-out of problematic alcohol use during emerging adulthood?
    PLoS One. 2020;15:e0220232.
    PubMed     Abstract available


  91. LUBMAN DI, Matthews S, Heilbronn C, Killian JJ, et al
    The National Ambulance Surveillance System: A novel method for monitoring acute alcohol, illicit and pharmaceutical drug related-harms using coded Australian ambulance clinical records.
    PLoS One. 2020;15:e0228316.
    PubMed     Abstract available


  92. KOVACS I, Demeter I, Janka Z, Demetrovics Z, et al
    Different aspects of impulsivity in chronic alcohol use disorder with and without comorbid problem gambling.
    PLoS One. 2020;15:e0227645.
    PubMed     Abstract available


  93. NING K, Gondek D, Patalay P, Ploubidis GB, et al
    The association between early life mental health and alcohol use behaviours in adulthood: A systematic review.
    PLoS One. 2020;15:e0228667.
    PubMed     Abstract available


  94. MEKONEN HH, Birhanu MM, Mossie TB, Gebreslassie HT, et al
    Factors associated with stroke among adult patients with hypertension in Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia, 2018: A case-control study.
    PLoS One. 2020;15:e0228650.
    PubMed     Abstract available


  95. MAGWOOD O, Salvalaggio G, Beder M, Kendall C, et al
    The effectiveness of substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder.
    PLoS One. 2020;15:e0227298.
    PubMed     Abstract available


  96. WOO YS, Yoon BH, Song JH, Seo JS, et al
    Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: A retrospective study.
    PLoS One. 2020;15:e0227217.
    PubMed     Abstract available


  97. LIN TC, Chien WC, Hu JM, Tzeng NS, et al
    Risk of colorectal cancer in patients with alcoholism: A nationwide, population-based nested case-control study.
    PLoS One. 2020;15:e0232740.
    PubMed     Abstract available


  98. FEDE SJ, Abrahao KP, Cortes CR, Grodin EN, et al
    Alcohol effects on globus pallidus connectivity: Role of impulsivity and binge drinking.
    PLoS One. 2020;15:e0224906.
    PubMed     Abstract available


  99. YITAYIH Y, Soboka M, Tesfaye E, Abera M, et al
    A cross-sectional study of psychopathy and khat abuse among prisoners in the correctional institution in Jimma, Ethiopia.
    PLoS One. 2020;15:e0227405.
    PubMed     Abstract available


  100. ALBAKHEET SS, Yoon H, Shin HJ, Koh H, et al
    Bone marrow fat change in pediatric patients with non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0234096.
    PubMed     Abstract available


  101. HUGHES TL, Veldhuis CB, Drabble LA, Wilsnack SC, et al
    Research on alcohol and other drug (AOD) use among sexual minority women: A global scoping review.
    PLoS One. 2020;15:e0229869.
    PubMed     Abstract available


  102. NICHOLS PH, Pan Y, May B, Pavlicova M, et al
    Effect of TSH on Non-Alcoholic Fatty Liver Disease (NAFLD) independent of obesity in children of predominantly Hispanic/Latino ancestry by causal mediation analysis.
    PLoS One. 2020;15:e0234985.
    PubMed     Abstract available


  103. AGUIRRE CG, Stolyarova A, Das K, Kolli S, et al
    Sex-dependent effects of chronic intermittent voluntary alcohol consumption on attentional, not motivational, measures during probabilistic learning and reversal.
    PLoS One. 2020;15:e0234729.
    PubMed     Abstract available


  104. GLASNER S, Chokron Garneau H, Ang A, Ray L, et al
    Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial.
    PLoS One. 2020;15:e0229557.
    PubMed     Abstract available


  105. GONZALES P, Grieco A, White E, Ding R, et al
    Safety of oral naltrexone in HIV-positive men who have sex with men and transgender women with alcohol use disorder and initiating antiretroviral therapy.
    PLoS One. 2020;15:e0228433.
    PubMed     Abstract available


  106. ALDRIDGE LR, Garman EC, Luitel NP, Jordans MJD, et al
    Impact of a district mental health care plan on suicidality among patients with depression and alcohol use disorder in Nepal.
    PLoS One. 2020;15:e0231158.
    PubMed     Abstract available


  107. FLENTJE A, Barger BT, Capriotti MR, Lubensky ME, et al
    Screening gender minority people for harmful alcohol use.
    PLoS One. 2020;15:e0231022.
    PubMed     Abstract available


  108. DIESINGER T, Buko V, Lautwein A, Dvorsky R, et al
    Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    PLoS One. 2020;15:e0235990.
    PubMed     Abstract available


  109. HEINSCH M, Sampson D, Huens V, Handley T, et al
    Understanding ambivalence in help-seeking for suicidal people with comorbid depression and alcohol misuse.
    PLoS One. 2020;15:e0231647.
    PubMed     Abstract available


  110. GRAZIANI R, Venturini S
    A Bayesian approach to discrete multiple outcome network meta-analysis.
    PLoS One. 2020;15:e0231876.
    PubMed     Abstract available


  111. FAINI D, Hanson C, Baisley K, Kapiga S, et al
    Sexual behaviour, changes in sexual behaviour and associated factors among women at high risk of HIV participating in feasibility studies for prevention trials in Tanzania.
    PLoS One. 2020;15:e0231766.
    PubMed     Abstract available


  112. SMITH ML, Lopez MF, Wolen AR, Becker HC, et al
    Brain regional gene expression network analysis identifies unique interactions between chronic ethanol exposure and consumption.
    PLoS One. 2020;15:e0233319.
    PubMed     Abstract available


  113. GHANDOUR LA, Anouti S, Afifi RA
    The impact of DSM classification changes on the prevalence of alcohol use disorder and 'diagnostic orphans' in Lebanese college youth: Implications for epidemiological research, health practice, and policy.
    PLoS One. 2020;15:e0233657.
    PubMed     Abstract available


  114. SERPER M, Vujkovic M, Kaplan DE, Carr RM, et al
    Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
    PLoS One. 2020;15:e0237430.
    PubMed     Abstract available


  115. CHEN K, Sng WK, Quah JH, Liu J, et al
    Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    PLoS One. 2020;15:e0236977.
    PubMed     Abstract available


  116. BAIK I, Park SI
    Associations of alcohol consumption and physical activity with lean type 2 diabetes mellitus among Korean adults: A prospective cohort study.
    PLoS One. 2020;15:e0238641.
    PubMed     Abstract available


  117. RAJCIC D, Brandt A, Jin CJ, Sanchez V, et al
    Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance.
    PLoS One. 2020;15:e0237946.
    PubMed     Abstract available


  118. FUKUSHIMA S, Kuga H, Oribe N, Mutou T, et al
    Behavioural cue reactivity to alcohol-related and non-alcohol-related stimuli among individuals with alcohol use disorder: An fMRI study with a visual task.
    PLoS One. 2020;15:e0229187.
    PubMed     Abstract available


  119. LEE J, Vali Y, Boursier J, Duffin K, et al
    Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0238717.
    PubMed     Abstract available


  120. FRAZAO DR, Maia CDSF, Chemelo VDS, Monteiro D, et al
    Ethanol binge drinking exposure affects alveolar bone quality and aggravates bone loss in experimentally-induced periodontitis.
    PLoS One. 2020;15:e0236161.
    PubMed     Abstract available


  121. SAWYER KS, Adra N, Salz DM, Kemppainen MI, et al
    Hippocampal subfield volumes in abstinent men and women with a history of alcohol use disorder.
    PLoS One. 2020;15:e0236641.
    PubMed     Abstract available


  122. SORINO P, Caruso MG, Misciagna G, Bonfiglio C, et al
    Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study.
    PLoS One. 2020;15:e0240867.
    PubMed     Abstract available


  123. CHEN F, Xiao M, Chen C, Chen C, et al
    Discrimination of alcohol dependence based on the convolutional neural network.
    PLoS One. 2020;15:e0241268.
    PubMed     Abstract available


  124. MANN JP, Carter P, Armstrong MJ, Abdelaziz HK, et al
    Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
    PLoS One. 2020;15:e0241357.
    PubMed     Abstract available


  125. HENNEIN R, Lowe S
    A hybrid inductive-abductive analysis of health workers' experiences and wellbeing during the COVID-19 pandemic in the United States.
    PLoS One. 2020;15:e0240646.
    PubMed     Abstract available


  126. SAKAMAKI A, Yokoyama K, Koyama K, Morita S, et al
    Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis.
    PLoS One. 2020;15:e0242582.
    PubMed     Abstract available


  127. ADRAWA N, Alege JB, Izudi J
    Alcohol consumption increases non-adherence to ART among people living with HIV enrolled to the community-based care model in rural northern Uganda.
    PLoS One. 2020;15:e0242801.
    PubMed     Abstract available


  128. BAE CR, Zhang H, Kwon YG
    The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2020;15:e0243497.
    PubMed     Abstract available


  129. VIANA PVS, Paiva NS, Villela DAM, Bastos LS, et al
    Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis.
    PLoS One. 2020;15:e0240090.
    PubMed     Abstract available


  130. LUONG XG, Stevens SK, Jekle A, Lin TI, et al
    Regulation of gene transcription by thyroid hormone receptor beta agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
    PLoS One. 2020;15:e0240338.
    PubMed     Abstract available


  131. VORNHOLT E, Drake J, Mamdani M, McMichael G, et al
    Network preservation reveals shared and unique biological processes associated with chronic alcohol abuse in NAc and PFC.
    PLoS One. 2020;15:e0243857.
    PubMed     Abstract available


  132. RADCLIFFE RA, Dowell R, Odell AT, Richmond PA, et al
    Systems genetics analysis of the LXS recombinant inbred mouse strains:Genetic and molecular insights into acute ethanol tolerance.
    PLoS One. 2020;15:e0240253.
    PubMed     Abstract available


  133. FRANK K, Abeynaike S, Nikzad R, Patel RR, et al
    Alcohol dependence promotes systemic IFN-gamma and IL-17 responses in mice.
    PLoS One. 2020;15:e0239246.
    PubMed     Abstract available


  134. SEMMLER G, Bachmayer S, Wernly S, Wernly B, et al
    Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0244514.
    PubMed     Abstract available


  135. KILIAN C, Manthey J, Moskalewicz J, Scafato E, et al
    Comparing subjective intoxication with risky single-occasion drinking in a European sample.
    PLoS One. 2020;15:e0241433.
    PubMed     Abstract available


  136. LONG JE, Richardson BA, Wanje G, Wilson KS, et al
    Alcohol use and viral suppression in HIV-positive Kenyan female sex workers on antiretroviral therapy.
    PLoS One. 2020;15:e0242817.
    PubMed     Abstract available


  137. TAVANASEFAT H, Li F, Koyano K, Gourtani BK, et al
    Molecular consequences of fetal alcohol exposure on amniotic exosomal miRNAs with functional implications for stem cell potency and differentiation.
    PLoS One. 2020;15:e0242276.
    PubMed     Abstract available


  138. KAN CK, Ragan EJ, Sarkar S, Knudsen S, et al
    Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India.
    PLoS One. 2020;15:e0240595.
    PubMed     Abstract available


  139. SEGHER K, Huys L, Desmet T, Steen E, et al
    Recognition of a disulfiram ethanol reaction in the emergency department is not always straightforward.
    PLoS One. 2020;15:e0243222.
    PubMed     Abstract available


  140. BITEW MS, Zewde MF, Wubetu M, Alemu AA, et al
    Consumption of alcohol and binge drinking among pregnant women in Addis Ababa, Ethiopia: Prevalence and determinant factors.
    PLoS One. 2020;15:e0243784.
    PubMed     Abstract available


  141. IGLESIAS K, Lannoy S, Sporkert F, Daeppen JB, et al
    Performance of self-reported measures of alcohol use and of harmful drinking patterns against ethyl glucuronide hair testing among young Swiss men.
    PLoS One. 2020;15:e0244336.
    PubMed     Abstract available


    January 2019
  142. HAGSTROM H, Widman L, von Seth E
    Association between temperature, sunlight hours and alcohol consumption.
    PLoS One. 2019;14:e0223312.
    PubMed     Abstract available


  143. TANAREE A, Assanangkornchai S, Isaranuwatchai W, Thavorn K, et al
    Integrated treatment program for alcohol related problems in community hospitals, Songkhla province of Thailand: A social return on investment analysis.
    PLoS One. 2019;14:e0209210.
    PubMed     Abstract available


  144. NAVARRO VJ, Belle SH, D'Amato M, Afdhal N, et al
    Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.
    PLoS One. 2019;14:e0223915.
    PubMed     Abstract available


  145. MARTINELLI JL, Germano CMR, de Avo LRDS, Fontanella BJB, et al
    Motivation for alcohol consumption or abstinence during pregnancy: A clinical-qualitative study in Brazil.
    PLoS One. 2019;14:e0223351.
    PubMed     Abstract available


  146. NIRIELLA MA, Kasturiratna A, Beddage T, Ediriweera DS, et al
    Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.
    PLoS One. 2019;14:e0224474.
    PubMed     Abstract available


  147. MADDEN M, Morris S, Stewart D, Atkin K, et al
    Conceptualising alcohol consumption in relation to long-term health conditions: Exploring risk in interviewee accounts of drinking and taking medications.
    PLoS One. 2019;14:e0224706.
    PubMed     Abstract available


  148. MINAMI Y, Kanemura S, Kawai M, Nishino Y, et al
    Alcohol consumption and survival after breast cancer diagnosis in Japanese women: A prospective patient cohort study.
    PLoS One. 2019;14:e0224797.
    PubMed     Abstract available


  149. ERHARTOVA D, Cahova M, Dankova H, Heczkova M, et al
    Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.
    PLoS One. 2019;14:e0224820.
    PubMed     Abstract available


  150. LEE YJ, Shu MS, Kim JY, Kim YH, et al
    Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway.
    PLoS One. 2019;14:e0211415.
    PubMed     Abstract available


  151. XIONG X, Yu J, Fan R, Zhang C, et al
    NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.
    PLoS One. 2019;14:e0212523.
    PubMed     Abstract available


  152. STADLBAUER V, Horvath A, Komarova I, Schmerboeck B, et al
    A single alcohol binge impacts on neutrophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers.
    PLoS One. 2019;14:e0211703.
    PubMed     Abstract available


  153. AL WAHAIBI N, Al Lawati A, Al Ruqeishy F, Al Khatri A, et al
    The characteristics and patterns of utilization of healthcare services among Omanis with substance use disorders attending therapy for cessation.
    PLoS One. 2019;14:e0210532.
    PubMed     Abstract available


  154. SU RC, Lad A, Breidenbach JD, Blomquist TM, et al
    Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2019;14:e0225604.
    PubMed     Abstract available


  155. SCOTT C, Stokes R, Cha KM, Clouston A, et al
    Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis.
    PLoS One. 2019;14:e0225332.
    PubMed     Abstract available


  156. PHAM TT, Park B
    Alcohol use disorder and health-related quality of life in Korean night-shift workers: A cross-sectional study using the KNHANES 2007-2015 data.
    PLoS One. 2019;14:e0214593.
    PubMed     Abstract available


  157. GARCIA-MARCHENA N, Barrera M, Mestre-Pinto JI, Araos P, et al
    Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders.
    PLoS One. 2019;14:e0213791.
    PubMed     Abstract available


  158. MIN-DEBARTOLO J, Schlerman F, Akare S, Wang J, et al
    Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    PLoS One. 2019;14:e0226854.
    PubMed     Abstract available


  159. SIEGFRIED N, Parry C
    Do alcohol control policies work? An umbrella review and quality assessment of systematic reviews of alcohol control interventions (2006 - 2017).
    PLoS One. 2019;14:e0214865.
    PubMed     Abstract available


  160. CASTANEDA SF, Garcia ML, Lopez-Gurrola M, Stoutenberg M, et al
    Alcohol use, acculturation and socioeconomic status among Hispanic/Latino men and women: The Hispanic Community Health Study/Study of Latinos.
    PLoS One. 2019;14:e0214906.
    PubMed     Abstract available


  161. FEIGL AB, Goryakin Y, Devaux M, Lerouge A, et al
    The short-term effect of BMI, alcohol use, and related chronic conditions on labour market outcomes: A time-lag panel analysis utilizing European SHARE dataset.
    PLoS One. 2019;14:e0211940.
    PubMed     Abstract available


  162. SILEO KM, Kizito W, Wanyenze RK, Chemusto H, et al
    Substance use and its effect on antiretroviral treatment adherence among male fisherfolk living with HIV/AIDS in Uganda.
    PLoS One. 2019;14:e0216892.
    PubMed     Abstract available


  163. BAROCAS JA, So-Armah K, Cheng DM, Lioznov D, et al
    Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naive persons with alcohol use in Russia.
    PLoS One. 2019;14:e0218852.
    PubMed     Abstract available


  164. GRAZIOLI VS, Gmel G, Rougemont-Bucking A, Baggio S, et al
    Attention deficit hyperactivity disorder and future alcohol outcomes: Examining the roles of coping and enhancement drinking motives among young men.
    PLoS One. 2019;14:e0218469.
    PubMed     Abstract available


  165. SILVER D, Macinko J, Giorgio M, Bae JY, et al
    Evaluating the relationship between binge drinking rates and a replicable measure of U.S. state alcohol policy environments.
    PLoS One. 2019;14:e0218718.
    PubMed     Abstract available


  166. LOPEZ V, Paladines B, Vaca S, Cacho R, et al
    Psychometric properties and factor structure of an Ecuadorian version of the Alcohol Use Disorders Identification Test (AUDIT) in college students.
    PLoS One. 2019;14:e0219618.
    PubMed     Abstract available


  167. LASOTA D, Goniewicz M, Kosson D, Ochal A, et al
    The effect of ethyl alcohol on the severity of injuries in fatal pedestrian victims of traffic crashes.
    PLoS One. 2019;14:e0221749.
    PubMed     Abstract available


  168. KNOX J, Schneider J, Greene E, Nicholson J, et al
    Using social network analysis to examine alcohol use among adults: A systematic review.
    PLoS One. 2019;14:e0221360.
    PubMed     Abstract available


  169. THOMAS BE, Thiruvengadam K, S R, Kadam D, et al
    Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored.
    PLoS One. 2019;14:e0220507.
    PubMed     Abstract available


  170. KAUNE T, Hollenbach M, Keil B, Chen JM, et al
    Common variants in glyoxalase I do not increase chronic pancreatitis risk.
    PLoS One. 2019;14:e0222927.
    PubMed     Abstract available


  171. MARMET S, Studer J, Lemoine M, Grazioli VS, et al
    Reconsidering the associations between self-reported alcohol use disorder and mental health problems in the light of co-occurring addictions in young Swiss men.
    PLoS One. 2019;14:e0222806.
    PubMed     Abstract available


  172. KNERICH V, Jones AA, Seyedin S, Siu C, et al
    Social and structural factors associated with substance use within the support network of adults living in precarious housing in a socially marginalized neighborhood of Vancouver, Canada.
    PLoS One. 2019;14:e0222611.
    PubMed     Abstract available


  173. ZUCKERMAN AD, Douglas A, Whelchel K, Choi L, et al
    Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
    PLoS One. 2019;14:e0225434.
    PubMed     Abstract available


  174. CALLING S, Ohlsson H, Sundquist J, Sundquist K, et al
    Socioeconomic status and alcohol use disorders across the lifespan: A co-relative control study.
    PLoS One. 2019;14:e0224127.
    PubMed     Abstract available


  175. AFSHAR M, Joyce C, Dligach D, Sharma B, et al
    Subtypes in patients with opioid misuse: A prognostic enrichment strategy using electronic health record data in hospitalized patients.
    PLoS One. 2019;14:e0219717.
    PubMed     Abstract available


  176. JIMENEZ VM JR, Settles EW, Currie BJ, Keim PS, et al
    Persistence of Burkholderia thailandensis E264 in lung tissue after a single binge alcohol episode.
    PLoS One. 2019;14:e0218147.
    PubMed     Abstract available


  177. FANTILLI AC, Trinks J, Marciano S, Zarate F, et al
    Unexpected high seroprevalence of hepatitis E virus in patients with alcohol-related cirrhosis.
    PLoS One. 2019;14:e0224404.
    PubMed     Abstract available


  178. GOLDSTICK JE, Walton MA, Bohnert ASB, Heinze JE, et al
    Predictors of alcohol use transitions among drug-using youth presenting to an urban emergency department.
    PLoS One. 2019;14:e0227140.
    PubMed     Abstract available


  179. VERHEIJ C, Rood PPM, Deelstra CK, Levendag MLL, et al
    Emergency Department visits due to intoxications in a Dutch university hospital: Occurrence, characteristics and health care costs.
    PLoS One. 2019;14:e0226029.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alcoholism is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: